Inès Holzbaur
Fondatore presso AmorChem Financial, Inc.
Profilo
Inès Holzbaur is the founder and the Managing Partner of AmorChem Financial, Inc., which was founded in 2011.
She is currently the Director at Aegera Therapeutics, Inc., AgeChem Financial, Inc., and SpecificiT Pharma, Inc. Additionally, she is the General Partner at GeneChem Management, Inc., a position she has held since 1999.
Dr. Holzbaur has also held former positions as a Director at BioVex Group, Inc., Argos Therapeutics, Inc., Réseau Capital, and Nuchem Therapeutics, Inc. She holds a doctorate degree from the University of Cambridge and an undergraduate degree from Concordia University-Irvine.
Posizioni attive di Inès Holzbaur
| Società | Posizione | Inizio |
|---|---|---|
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investitore di Private Equity | 01/01/1999 |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Direttore/Membro del Consiglio | - |
SpecificiT Pharma, Inc.
 SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada. | Direttore/Membro del Consiglio | - |
AgeChem Financial, Inc.
 AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
AmorChem Financial, Inc.
 AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada. | Fondatore | 01/01/2011 |
Precedenti posizioni note di Inès Holzbaur
| Società | Posizione | Fine |
|---|---|---|
Nuchem Therapeutics, Inc.
 Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | - |
Réseau Capital
 Réseau Capital Miscellaneous Commercial ServicesCommercial Services Réseau Capital operates as a venture capital and private equity association. It promotes private equity industry in Quebec through training, information and promotion, networking, and representation. The company was founded by Jean-Pierre Chartrand in 1989 and is headquartered in Montréal, Canada. | Direttore/Membro del Consiglio | - |
| ARGOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - |
Formazione di Inès Holzbaur
| University of Cambridge | Doctorate Degree |
| Concordia University-Irvine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
GeneChem Management, Inc.
GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Finance |
Réseau Capital
Réseau Capital Miscellaneous Commercial ServicesCommercial Services Réseau Capital operates as a venture capital and private equity association. It promotes private equity industry in Quebec through training, information and promotion, networking, and representation. The company was founded by Jean-Pierre Chartrand in 1989 and is headquartered in Montréal, Canada. | Commercial Services |
AgeChem Financial, Inc.
AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Finance |
AmorChem Financial, Inc.
AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada. | Finance |
SpecificiT Pharma, Inc.
SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada. | Commercial Services |
Nuchem Therapeutics, Inc.
Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Inès Holzbaur
